Search - tctmd.com

Displaying 101 - 120 of 128

Sort: Relevancy | Date

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

MAQUET Cardiovascular Receives CE Mark For INTERGARD SYNERGY Vascular Graft

June 19, 2012

News Industry News

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

April 25, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

News Industry News

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

February 01, 2012

News Industry News

Use of proximal balloon occlusion results in fewer cerebral ischemic lesions than filters after carotid artery stenting

November 10, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

November 07, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

November 04, 2011

News Industry News

Emboline, Inc. to Debut Game-Changing Embolic Protection Technology for Percutaneous Heart Valve Procedures in San Francisco Next Week

November 02, 2011

News Industry News

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

October 14, 2011

News Industry News

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

September 22, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011

News Industry News

First Patient Enrolls in St. Jude Medical Supported Landmark Study Investigating Atrial Fibrillation Treatment Options

August 02, 2011

News Industry News

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

July 11, 2011

News Industry News

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

June 02, 2011

News Industry News

Health Canada approves BRILINTA (ticagrelor tablets)

June 01, 2011

News Industry News

Johns Hopkins to Address Topics in Atrial Fibrillation, Interventional Cardiology and Lipids Live Online at CardioCareLive June 28th and 29th

May 24, 2011

Advertisement

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

MAQUET Cardiovascular Receives CE Mark For INTERGARD SYNERGY Vascular Graft

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

Use of proximal balloon occlusion results in fewer cerebral ischemic lesions than filters after carotid artery stenting

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Emboline, Inc. to Debut Game-Changing Embolic Protection Technology for Percutaneous Heart Valve Procedures in San Francisco Next Week

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

First Patient Enrolls in St. Jude Medical Supported Landmark Study Investigating Atrial Fibrillation Treatment Options

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

Health Canada approves BRILINTA (ticagrelor tablets)

Johns Hopkins to Address Topics in Atrial Fibrillation, Interventional Cardiology and Lipids Live Online at CardioCareLive June 28th and 29th

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content